ARCHIVES

Bush Nominates Health Policy Advisor McClellan For FDA Commissioner

This article is from The Cancer Letter archive.

Vol. 28 No. 35 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

October 3, 2014

DCT Bard Okays Concepts for BRMP Contract Programs

June 22, 1984

ONS, ASCO, AACR Growth Surge Continues; Flex Political Muscles During DC Meetings

June 8, 1990

FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court.

January 15, 2010

NCI Offers Fellowship Training In Epidemiology & Genetics.

February 18, 2000

In Brief: RFP Offers Patent Rights Instead Of Profit; ACS, NCI Plan More Joint Projects; BC Report Sept. 30

September 20, 1974